Medicus Pharma (MDCX) Invested Capital (2023 - 2025)

Medicus Pharma has reported Invested Capital for 3 years, with the latest figure at $5.2 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 65.18% year-over-year to $5.2 million; the trailing twelve-month figure through Dec 2025 stood at $5.2 million (up 65.18% YoY), and the FY2025 full-year result was $5.2 million, up 65.18% from the prior year.
• Invested Capital for Q4 2025 stood at $5.2 million, down from $5.9 million in the prior quarter.
• The five-year high for Invested Capital was $7.9 million in Q2 2025, with the low at -$559957.0 in Q1 2024.
• Historically, Invested Capital has averaged $4.1 million across 3 years, with a median of $4.8 million in 2024.
• The largest YoY upside for Invested Capital was 483.52% in 2025 against a maximum downside of 12.37% in 2025.
• Medicus Pharma's Invested Capital stood at $1.1 million in 2023, then jumped by 182.04% to $3.1 million in 2024, then soared by 65.18% to $5.2 million in 2025.
• The last three Invested Capital figures came in at $5.2 million (Q4 2025), $5.9 million (Q3 2025), and $7.9 million (Q2 2025), per Business Quant data.